Form D · Pharmaceuticals
Pharmaxis Ltd.
New South Wales, C3 · CIK 0001301357
Offering snapshot reported Jun 19, 2009 · SEC filing
- Reported sold
- $1.39M Offering amount: $1.39M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $452K Reported outside-investor minimum
- First sale
- Jun 4, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2009 | Initial | $1,394,437 | No comparison | 2 | SEC filing |
| Oct 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $500K
- Finders' fees
- $0
- Form D file number
- 021-110320
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| JMP Securities LLC | 22208 |
Source: Form D, filed Jun 19, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brett Charlton | Executive |
| John F. Crapper | Executive |
| William Delaat | Director |
| Peter C. Farrell | Director |
| Denis M. Hanley | Director |
| Malcom J. Mc Comas | Director |
| Ian A. Mc Donald | Executive |
| David M. Mc Garvey | Executive |
| Gary J. Phillips | Executive |
| Alan D. Robertson | Director, Executive |
| John Villiger | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2/10 Rodborough Road, Frenchs Forest
New South Wales, C3, 2086
New South Wales, C3, 2086